DK0980874T3 - Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer - Google Patents

Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer

Info

Publication number
DK0980874T3
DK0980874T3 DK99115386T DK99115386T DK0980874T3 DK 0980874 T3 DK0980874 T3 DK 0980874T3 DK 99115386 T DK99115386 T DK 99115386T DK 99115386 T DK99115386 T DK 99115386T DK 0980874 T3 DK0980874 T3 DK 0980874T3
Authority
DK
Denmark
Prior art keywords
improved method
properly connected
cysteine bridges
insulin precursors
recovering insulin
Prior art date
Application number
DK99115386T
Other languages
Danish (da)
English (en)
Inventor
Franz-Josef Dr Rubroeder
Reinhold Dr Keller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0980874T3 publication Critical patent/DK0980874T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99115386T 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer DK0980874T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19735711A DE19735711C2 (de) 1997-08-18 1997-08-18 Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
DK0980874T3 true DK0980874T3 (da) 2002-08-19

Family

ID=7839275

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99115386T DK0980874T3 (da) 1997-08-18 1998-08-11 Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer
DK98115048T DK0906918T3 (da) 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98115048T DK0906918T3 (da) 1997-08-18 1998-08-11 Fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cystinbroer

Country Status (20)

Country Link
US (3) US5986048A (enExample)
EP (2) EP0980874B1 (enExample)
JP (1) JP4291900B2 (enExample)
KR (2) KR100537842B1 (enExample)
CN (3) CN101186940B (enExample)
AR (1) AR016821A1 (enExample)
AT (2) ATE217636T1 (enExample)
AU (1) AU744824B2 (enExample)
BR (2) BR9803755A (enExample)
CA (1) CA2245151C (enExample)
CZ (1) CZ295679B6 (enExample)
DE (3) DE19735711C2 (enExample)
DK (2) DK0980874T3 (enExample)
ES (2) ES2176870T3 (enExample)
HU (2) HU228161B1 (enExample)
ID (1) ID20717A (enExample)
PL (1) PL191901B1 (enExample)
PT (2) PT980874E (enExample)
RU (2) RU2205836C2 (enExample)
TR (1) TR199801587A3 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19930676B4 (de) 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
JP2003530316A (ja) 1999-12-22 2003-10-14 ノボ ノルディスク アクティーゼルスカブ スクランブルした一本鎖ポリペプチドの抽出的再生法
AU2001280436A1 (en) * 2000-07-12 2002-01-21 Eli Lilly And Company Process to increase protein stability
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
JP5036727B2 (ja) 2005-12-22 2012-09-26 ジェネンテック, インコーポレイテッド ヘパリン結合タンパク質の組み換え体産生
CN101506222B (zh) * 2006-07-14 2013-10-02 健泰科生物技术公司 重组蛋白的重折叠
CA2692585A1 (en) * 2007-07-03 2010-01-04 Amgen Inc. Measurement of protein using inclusion body dry weight
RU2451750C2 (ru) * 2007-09-24 2012-05-27 Общество С Ограниченной Ответственностью "Герофарм" Способ получения рекомбинантного с-пептида проинсулина человека
BRPI0907371A2 (pt) 2008-01-09 2015-11-24 Sanofi Aventis Deutschland derivados de insulina com um perfil de tempo-ação muito retardado
US9296806B2 (en) * 2008-04-30 2016-03-29 Wockhardt Limited Processes for refolding of insulin
RS59913B1 (sr) 2008-10-17 2020-03-31 Sanofi Aventis Deutschland Kombinacija insulina i glp-1-agonista
CA2780043C (en) 2009-11-13 2019-01-29 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist and methionine
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
WO2014133324A1 (ko) * 2013-02-26 2014-09-04 한미약품 주식회사 신규한 인슐린 아날로그 및 이의 용도
CN103694339B (zh) * 2013-12-04 2017-10-13 珠海联邦制药股份有限公司 一种甘精胰岛素前体的复性方法
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
CN104911203A (zh) * 2015-06-30 2015-09-16 成都易胜科生物科技有限公司 一种重组人胰岛素的工业制备方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2018018613A1 (zh) 2016-07-29 2018-02-01 广东东阳光药业有限公司 一种提高抗体纯度的细胞培养基和培养方法
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
CN113773391B (zh) * 2020-06-09 2023-10-20 宁波鲲鹏生物科技有限公司 一种门冬胰岛素的制备方法
CN113773396A (zh) * 2020-06-10 2021-12-10 宁波鲲鹏生物科技有限公司 一种地特胰岛素衍生物及其应用
JP7749397B2 (ja) * 2021-09-30 2025-10-06 キヤノン株式会社 超音波ファントム及び超音波ファントムの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
RU2045535C1 (ru) * 1991-06-18 1995-10-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ получения проинсулина человека
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
RU2081122C1 (ru) * 1994-06-16 1997-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН Способ выделения и очистки инсулина или его биотехнологических предшественников
PT871474E (pt) * 1994-12-29 2007-02-28 Ferring Int Ct Sa Produção de insulina humana
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
EP0980874B1 (de) 2002-05-02
TR199801587A2 (xx) 1999-03-22
HU228161B1 (en) 2013-01-28
CN1209437A (zh) 1999-03-03
HU9801886D0 (en) 1998-10-28
HUP9801886A3 (en) 1999-06-28
CA2245151C (en) 2009-10-06
EP0906918B1 (de) 2002-05-15
JPH11130798A (ja) 1999-05-18
ATE217012T1 (de) 2002-05-15
ES2177178T3 (es) 2002-12-01
CN1483831B (zh) 2012-06-13
HK1119449A1 (en) 2009-03-06
DE19735711A1 (de) 1999-02-25
HK1061870A1 (en) 2004-10-08
CN1483831A (zh) 2004-03-24
AU744824B2 (en) 2002-03-07
DE59804121D1 (de) 2002-06-20
ATE217636T1 (de) 2002-06-15
KR100574580B1 (ko) 2006-04-28
PL328108A1 (en) 1999-03-01
JP4291900B2 (ja) 2009-07-08
PT906918E (pt) 2002-10-31
US6727346B2 (en) 2004-04-27
CZ259898A3 (cs) 1999-03-17
HK1018464A1 (en) 1999-12-24
CN101186940A (zh) 2008-05-28
KR100537842B1 (ko) 2006-03-23
BRPI9816233B8 (pt) 2021-05-25
HUP9801886A2 (hu) 1999-01-28
CA2245151A1 (en) 1999-02-18
HU228203B1 (en) 2013-01-28
CN1132845C (zh) 2003-12-31
DE19735711C2 (de) 2001-04-26
RU2205836C2 (ru) 2003-06-10
TR199801587A3 (tr) 1999-03-22
HU0600287D0 (en) 2006-05-29
US20020156234A1 (en) 2002-10-24
CZ295679B6 (cs) 2005-09-14
KR19990023651A (ko) 1999-03-25
AU8076398A (en) 1999-02-25
US6380355B1 (en) 2002-04-30
EP0906918A2 (de) 1999-04-07
BR9803755A (pt) 2000-03-28
ES2176870T3 (es) 2002-12-01
KR20050067371A (ko) 2005-07-01
PT980874E (pt) 2002-10-31
RU2302882C2 (ru) 2007-07-20
US5986048A (en) 1999-11-16
EP0980874A1 (de) 2000-02-23
ID20717A (id) 1999-02-18
CN101186940B (zh) 2012-02-08
DE59803985D1 (de) 2002-06-06
BRPI9816233B1 (pt) 2016-09-27
DK0906918T3 (da) 2002-09-09
AR016821A1 (es) 2001-08-01
EP0906918A3 (de) 1999-08-11
PL191901B1 (pl) 2006-07-31

Similar Documents

Publication Publication Date Title
DK0980874T3 (da) Forbedret fremgangsmåde til udvinding af insulinforstadier med korrekt forbundne cysteinbroer
DK0914189T3 (da) Fremgangsmåde til genvinding af procesvæsker
DK1015388T3 (da) Fremgangsmåde til inhibering af biogen sulfiddannelse
DK1036179T3 (da) Fremgangsmåde til fremstilling af polypeptider med egnet glucosilering
DE59909597D1 (de) Verfahren zur kontrolle der insulinmedikation
NO20003050L (no) Metode for Õ administrere monomere insulinanaloger
NO20010982D0 (no) FremgangsmÕte for Õ administrere insulinotropiske peptider
DE69735527D1 (de) Digitales Verfahren zur adaptiven Taktrückgewinnung
DK1032565T3 (da) Fremgangsmåde til fremstilling af derivater af taxoid-klassen
FI970388A0 (fi) Menetelmä kuvasekvenssien kontrastin parantamiseksi
DK199901814A (da) Fremgangsmåde til fortætning af en naturgasstrøm, der indeholder mindst én frysbar komponent
DK1176195T3 (da) Fremgangsmåde til at kontrollere aktiviteten af immunologisk funktionelt molekyle
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1230247T3 (da) Fremgangsmåde til stabilisering af siloxanforbindelser
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DK0917879T3 (da) Forbedret fremgangsmåde til stabilisering af proteiner
DK1006816T3 (da) Fast sammensætning til mindskning af tanderosion
DE69928050D1 (de) Taktregenerator
DK0946531T3 (da) Fremgangsmåde til fremstilling af thiazol-derivater
DE69835190D1 (de) Schaltung zur Taktrückgewinnung
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK1308454T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
DK1062358T3 (da) Ny fremgangsmåde til fremstilling af fexofenadin
DK1053474T3 (da) Fremgangsmåde til bestemmelse af prostetiske infektioner
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer